Evaluates the protective effects of hesperidin on lung injury caused by dichlorvos, indicating its potential therapeutic use.
Dichlorvos (DDVP), an organophosphate insecticide, is associated with pulmonary toxicity. This study evaluated the protective effects of hesperidin, a citrus flavonoid with antioxidant properties, against DDVP-induced lung damage in rats. Forty-two rats were assigned to seven groups (n = 6 each): control, DDVP alone (8 mg/kg/day), DDVP plus hesperidin (50 and 100 mg/kg/day), DDVP plus atropine (0.2 mg/kg/day), and hesperidin alone (50 and 100 mg/kg/day). DDVP was administered orally for one week, followed by two weeks of hesperidin treatment. Biochemical analyses demonstrated that hesperidin significantly (p < 0.05) reduced DDVP-induced elevations in pulmonary cholesterol, phospholipids, hydrogen peroxide, nitric oxide, and malondialdehyde, while restoring triacylglycerol levels, reduced glutathione, and antioxidant enzyme activities including glutathione S-transferase, superoxide dismutase, catalase, and glutathione peroxidase. Histopathological examination confirmed amelioration of lung tissue damage. These findings suggest that hesperidin mitigates DDVP-induced pulmonary toxicity by alleviating oxidative stress and correcting lipid metabolism disturbances, highlighting its therapeutic potential against organophosphate-induced lung injury.
No takes yet. Share an insight, caveat, or question.
Chukwuemeka Ifediora Nwosu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: